Bioxcel therapeutics to participate in canaccord genuity 45th annual growth conference

New haven, conn., aug. 11, 2025 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that vimal mehta, ph.d.

BTAI Ratings Summary

BTAI Quant Ranking